Evidence map›Paper›PMID 32441410›Full record

ArticleAging cell2020

Exercise training reverses cardiac aging phenotypes associated with heart failure with preserved ejection fraction in male mice.

Jason D Roh, Nicholas Houstis, Andy Yu, Bliss Chang, Ashish Yeri, Haobo Li, Ryan Hobson, Carolin Lerchenmüller, Ana Vujic, Vinita Chaudhari and 7 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Exercise attenuates the hallmarks of aging: Novel perspectives.Journal of sport and health science · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Sexual dimorphism in animal models of heart failure with preserved ejection fraction.Journal of applied physiology (Bethesda, Md. : 1985) · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Jason D RohCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-6999-6868
Nicholas HoustisCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Andy YuCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Bliss ChangCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ashish YeriCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Haobo LiCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-5660-7835
Ryan HobsonCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-8370-8570
Carolin LerchenmüllerDepartment of Cardiology, Angiology, and Pulmonology, University Hospital Heidelberg, Heidelberg, Germany.
Ana VujicDepartment of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
Vinita ChaudhariCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Federico DamilanoCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Colin PlattCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Daniel ZlotoffCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Richard T LeeDepartment of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
Ravi ShahCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Michael Jerosch-HeroldDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Anthony RosenzweigCorrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Harvard University · USBrigham and Women's Hospital · USHeidelberg University · DE

Funding

Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular LevelR35HL155318 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANTHONY ROSENZWEIG · 2021 to 2026
$5.4M
Role of Activin Type II receptor signaling in age-related heart failureR01AG061034 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROSENZWEIG, ANTHONY · 2019 to 2023
$3.0M
A New Pathway for Reversing Cardiac AgingR01AG047131 · NIA · HARVARD UNIVERSITY · PI LEE, RICHARD T · 2015 to 2019
$1.7M
Reprogramming Non-myocytes to Cardiomyocytes in vivoR01HL119230 · NHLBI · HARVARD UNIVERSITY · PI LEE, RICHARD T · 2016 to 2019
$1.7M
Does Exercise Induce Cardiomyogenesis?R01HL122987 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 2014 to 2018
$1.7M
Role of miR-222 in pathological hypertrophy and heart failureR01HL135886 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 2017 to 2020
$1.7M
Activin type II receptor activity in age-related frailty and heart failureK76AG064328 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI ROH, JASON DAVID · 2019 to 2022
$972k
Discovery and characterization of lncRNAs involved in cardiac exercise phenotypesR01HL146464 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 2020 to 2020
$400k
NHLBI NIH HHS HL119230NHLBI NIH HHS HL122987NHLBI NIH HHS HL135886NHLBI NIH HHS R01 HL119230NHLBI NIH HHS R01 HL135886NHLBI NIH HHS R01 HL146464NHLBI NIH HHS R35 HL155318NIA NIH HHS AG047131NIA NIH HHS AG061034NIA NIH HHS AG064328NIA NIH HHS K76 AG064328NIA NIH HHS R01 AG061034
6 · The paper itself

Abstract

Heart failure with preserved ejection fraction (HFpEF) is the most common type of HF in older adults. Although no pharmacological therapy has yet improved survival in HFpEF, exercise training (ExT) has emerged as the most effective intervention to improving functional outcomes in this age-related disease. The molecular mechanisms by which ExT induces its beneficial effects in HFpEF, however, remain largely unknown. Given the strong association between aging and HFpEF, we hypothesized that ExT might reverse cardiac aging phenotypes that contribute to HFpEF pathophysiology and additionally provide a platform for novel mechanistic and therapeutic discovery. Here, we show that aged (24-30 months) C57BL/6 male mice recapitulate many of the hallmark features of HFpEF, including preserved left ventricular ejection fraction, subclinical systolic dysfunction, diastolic dysfunction, impaired cardiac reserves, exercise intolerance, and pathologic cardiac hypertrophy. Similar to older humans, ExT in old mice improved exercise capacity, diastolic function, and contractile reserves, while reducing pulmonary congestion. Interestingly, RNAseq of explanted hearts showed that ExT did not significantly modulate biological pathways targeted by conventional HF medications. However, it reversed multiple age-related pathways, including the global downregulation of cell cycle pathways seen in aged hearts, which was associated with increased capillary density, but no effects on cardiac mass or fibrosis. Taken together, these data demonstrate that the aged C57BL/6 male mouse is a valuable model for studying the role of aging biology in HFpEF pathophysiology, and provide a molecular framework for how ExT potentially reverses cardiac aging phenotypes in HFpEF.

Indexed as

AgingAnimalsEchocardiography, DopplerExerciseHeart FailureHumansMaleMicePhenotypeStroke Volumeagingcardiaccardiovascularexerciseheart failureRNA sequencing

Identifiers

PMID32441410
PMCPMC7294786
OpenAlexW3028532849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.